Completion of share buyback programme
Summary by AI BETAClose X
20 November 2025
IP Group plc
Completion of Share Buyback Programme
IP Group plc (LSE: IPO) ("IP Group" or "the Group"), announces that on 18 November 2025 it successfully completed the £20m extension to its share buyback programme that was originally announced on 26 June 2025.
Since commencing its buyback programme, the Group has purchased 157,968,634 shares at an average price of 47.5 pence per share for an aggregate consideration of £75m ("the Buyback Programme"). All shares acquired under the Buyback Programme have been, or will shortly be, cancelled.
Following such cancellation, the Company's issued share capital consists of 883,427,642 Ordinary Shares with voting rights and there are no Ordinary Shares held in treasury. This figure may be used by shareholders as the denominator for the calculations by which they should determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Share buybacks will remain an important part of IP Group's Capital Allocation Policy. The Group will keep further buybacks under review, subject to the achievement of additional realisations within the portfolio.
For more information, please contact:
|
IP Group plc |
www.ipgroupplc.com |
|
Liz Vaughan-Adams, Communications |
+44 (0) 20 7444 0062/+44 (0) 7967 312125 |
|
Portland |
|
|
Alex Donaldson |
+44 (0) 7516 729702 |
Notes for editors
About IP Group
IP Group accelerates the impact of science for a better future. As the most active UK based, early stage science investor, we develop and support some of the world's most exciting businesses in deeptech, life sciences and cleantech. Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, Featurespace, First Light Fusion, Hysata, and Oxa. IP Group is listed on the Main Market of the London
ENDS
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 11 hours ago Luceco
- 12 hours ago Helios Towers
- 12 hours ago Wise Class A
- 12 hours ago EDX Medical Group Plc
- 12 hours ago Naked Wines